Bullseyebiosciences
1 known investors
Bullseye Biosciences discovers drug molecules directly in living cells using directed evolution to target difficult intracellular proteins and protein interactions implicated in cancer and other serious diseases. The platform links molecular activity to biological function from the outset, avoiding the discovery-to-development gap typical of conventional in vitro screening.
AI & Machine LearningBiotechDeep Tech